Bison Wealth’s Quest Diagnostics DGX Stock Holding History

Bison Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,406	Closed	-$204K	–	190
2016 Q3	$204K	Buy	+2,406	New	+$202K	0.17%	163

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bison Wealth's DGX Position: Q4 2016 in Review

Bison Wealth sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 2,406 shares — an estimated $204K sold.

Bison Wealth first reported a position in DGX in Q3 2016 and held it in 1 quarter. The position peaked at $204K in Q3 2016. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

Bison Wealth reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
Bison Wealth sold 2,406 Quest Diagnostics shares in Q4 2016, an estimated $204K.
Bison Wealth first reported a position in Quest Diagnostics in Q3 2016 and held it in 1 quarter.
Bison Wealth's Quest Diagnostics position peaked at $204K in Q3 2016.
598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Bison Wealth's 13F filing for Q4 2016, filed 6 Feb 2017.